© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Mediterranean Diet Combined with Physical Activity Mitigate Bone Density Decline in Older, At-Risk Women, New Analysis Finds
April 15, 2025
Following a Mediterranean-style diet and a prescribed regimen of physical activity was significantly protective of BMD, particularly at the lumbar level, over 3 years.
Rachel Issaka, MD, MAS: Effective CRC Prevention Programs Require Multispecialty Commitment
April 11, 2025
ACP 2025. A focused CRC prevention program begins with primary care where support and advocacy for regular screening begins, Issaka stressed.
Dexcom G7 15 Day CGM System Cleared by FDA
April 10, 2025
The extended wear benefit is augmented by the G7 15 Day CGM system's superior evidence-based accuracy, with a MARD of 8.0%
Incretin-Based Obesity Medications Show Minimal Lean Muscle Mass Loss in 6-Month Prospective Study
April 10, 2025
Loss of lean muscle mass along with fat mass is a concerning side effect of the incretin-based antiobesity medications, making the new study results encouraging.
Failure to Follow-Up After Colorectal Cancer Screening Translates into Preventable Deaths: Rachel Issaka, MD, MAS
April 10, 2025
ACP 2025: Issaka, from the Fred Hutchinson Cancer Center, told internists that three-quarters of CRC deaths can be attributed to 3 types of screening failure.
Aprocitentan Reduces BP in Black Adults with Resistant Hypertension and Lowers Proteinuria
April 09, 2025
Aprocitentan, when added to background therapy of at least 3 antihypertensive agents, led to clinically meaningful and sustained BP reduction in this preplanned subanalysis.
Second Measles-Related Death in a Child Reported in Texas as US Cases Surpass 600
April 09, 2025
As the US measles outbreak tops 600 cases, Texas reported a second child's death in a young girl who was unvaccinated and had no underlying health conditions.
Primary Care Primer for Headache Management, with Morris Levin, MD
April 09, 2025
ACP 2025. The director of the UCSF Headache Center built an evidence-based framework for diagnosing and treating headache disorders seen in primary care.
Eisai Presents Real-World Lecanemab Data at AD/PD 2025 Confirming Phase 3 Clinical Trial Findings
April 08, 2025
In addition to support for phase 3 CLARITY AD findings, new evidence was presented supporting lecanemab safety and efficacy in ApoE ε4 carriers and non-carriers.
Alphyn Biologics Initiates Phase 2b Trial of Botanical Drug for Atopic Dermatitis
April 08, 2025
The investigational botanical zabalafin hydrogel has shown antipruritic, antibacterial, and anti-inflammatory properties, addressing the multifactorial nature of AD.